Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01941810 · ClinicalTrials.gov registry record · NA
Bovine Lactoferrin Supplement in Improving Taste in Patients With Cancer Receiving Chemotherapy
A NA study of Malignant Neoplasm and Cachexia, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
- 2
- Study locations
NCT01941810 is a NA study of Malignant Neoplasm and Cachexia that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 14 participants, below the 513-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT01941810, a NA study of Malignant Neoplasm and Cachexia, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
- 2
- Study locations
Study Summary
This pilot phase II trial studies how well bovine lactoferrin supplement works in improving taste in patients with cancer receiving chemotherapy. Bovine lactoferrin supplement may help improve the ability to taste food in patients who are receiving chemotherapy.
Conditions Studied
Interventions
- OTHER laboratory biomarker analysis
- OTHER questionnaire administration
- PROCEDURE quality-of-life assessment
- DIETARY_SUPPLEMENT bovine lactoferrin supplement
Study Locations (2)
North Carolina
- Comprehensive Cancer Center of Wake Forest University - Winston-Salem
Virginia
- Virginia Polytechnic Institute and State University - Blacksburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2014-02 |
| Est. Completion | 2015-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01941810
The ClinicalTrials.gov registry entry for NCT01941810 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 513-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (97% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Malignant Neoplasm appearing as the primary indexed condition, and to 4 interventions - of which laboratory biomarker analysis is the first listed.
NCT01941810 reports 2 study locations spanning 2 distinct geographic areas - top geographies include North Carolina, Virginia.
Frequently Asked Questions
What is clinical trial NCT01941810 about?
NCT01941810 is a clinical study titled "Bovine Lactoferrin Supplement in Improving Taste in Patients With Cancer Receiving Chemotherapy". This pilot phase II trial studies how well bovine lactoferrin supplement works in improving taste in patients with cancer receiving chemotherapy. Bovine lactoferrin supplement may help improve the ability to taste food in patients who are receiving chemotherapy.
What is the current status of trial NCT01941810?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2014-02. Estimated completion is 2015-10.
What conditions does trial NCT01941810 study?
This clinical trial studies the following conditions: Malignant Neoplasm, Cachexia, Anorexia, Oral Complications of Chemotherapy.
What interventions are being tested in trial NCT01941810?
The interventions under investigation include: laboratory biomarker analysis (OTHER), questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE), bovine lactoferrin supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01941810?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01941810 being conducted?
This trial has 2 study locations across North Carolina, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
RECRUITING · NA
-
Novel Outreach Methods to Increase Enrollment to Early Phase Clinical Trials
RECRUITING · NA
-
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
RECRUITING · NA
-
Decreasing Chemotherapy Induced Distress Using Immersive Virtual Reality in Patients With Cancer
RECRUITING · NA
-
A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant
RECRUITING · NA
-
Reproductive Health Program in Patients With Cancer
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.